Insightful and informative, as always. ZF, thank you for your contributions to this board and for the service you do long-term investors in putting many events into clearer perspective.
Someone (I can't recall who) posted on this board Dr. Seymour's e-mail/statement, and I am paraphrasing, "...is difficult to find staff with the necessary qualifications in Biomedical Engineering,...requiring a minimum of hand holding...". Then we read this...
Also, with this additional capital the company anticipates being able to hire necessary staff to accommodate the expanded workload as it gears several of its drug candidates towards IND filingsover the near future. In addition, the company will be able to continue its R&D programmes, such as nanoviricides against Rabies and Ebola/Marburg viruses.
NanoViricides, Inc. is making human capital investments and I for one expect this year, and those that will follow, to be nothing short from spectacular!
News 
Market Data 
Discover 
AI
